title: Solar urticaria in the visible spectrum successfully treated with astemizole.
abstract: Three cases of solar urticaria in the visible spectrum successfully treated with astemizole, a H1 antihistamine, are reported. The administration of 10 mg a day of the drug increased the minimal urticarial dose from 2 to 12 times.
authors.affiliation: Department of Dermatology, 2nd Faculty of Medicine, University of Naples, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Monfrecola
authors.forename: P
authors.initials: P
authors.lastname: Nappa
authors.forename: D
authors.initials: D
authors.lastname: Pini
mesh_terms: D000328:Adult; D016589:Astemizole; D001562:Benzimidazoles / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006634:Histamine H1 Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged; D013472:Sunlight / Q000009:adverse effects*; D014581:Urticaria / Q000188:drug therapy* / Q000209:etiology
chemical_list: D001562:Benzimidazoles; D006634:Histamine H1 Antagonists; D016589:Astemizole